CF-PA²Vtech: a cell-free human protein array technology for antibody validation against human proteins

Area of Science:

• Biotechnology
• Immunology
• Proteomics

Background:

• Antibody specificity is crucial for accurate detection of biological molecules.
• Confirming antibody specificity is challenging, impacting research reliability.
• A large-scale human protein array was developed using a wheat cell-free system.

Purpose of the Study:

• To demonstrate a novel protein array technology for antibody validation (CF-PA2Vtech).
• To assess the specificity and cross-reactivity of commercially available antibodies.
• To establish a reliable method for validating antibodies against human proteins.

Main Methods:

• Constructed a human protein array with 19,712 recombinant proteins via wheat cell-free synthesis.
• Utilized glutathione-conjugated magnetic beads for protein capture in a high-throughput format.
• Employed immunoblotting and alanine mutagenesis to confirm antibody cross-reactivity and epitope mapping.

Main Results:

• The CF-PA2Vtech successfully identified cross-reactivity for anti-HA (13 proteins) and anti-PD-1 (3 proteins) antibodies.
• Cross-reactive proteins shared similar epitopes, which were further validated by alanine mutations.
• Demonstrated the utility of the protein array for assessing antibody specificity.

Conclusions:

• CF-PA2Vtech is a powerful tool for validating antibody specificity against human proteins.
• The technology enhances the reliability of antibody-based detection methods.
• This platform facilitates the development and quality control of antibodies for research and clinical applications.